Charles Mathews's Net Worth

-$24.9 Thousand

Estimate Recalculated Sep 8, 2024 07:38PM EST

Who is Charles Mathews?

Charles Mathews does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LPATH, INC, and AVANIR PHARMACEUTICALS, INC..

SEC CIK

Charles Mathews's CIK is 0001190315

Past Insider Trading and Trends

2012 was Charles Mathews's most active year for acquiring shares with 4 total transactions. Charles Mathews's most active month to acquire stocks was the month of January. 2012 was Charles Mathews's most active year for disposing of shares, totalling 1 transactions. Charles Mathews's most active month to dispose stocks was the month of January. 2006 saw Charles Mathews paying a total of $62,500.00 for 56,435 shares, this is the most they've acquired in one year. In 2015 Charles Mathews cashed out on 5,715 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LPATH, INC No price found

Investor

Charles Mathews owns 10,716 units of Class A Common Stock and 19,916 units of Common Stock. In the year 2006 Charles Mathews filed a total of 16 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
+21.21%
3.48K
—
—
19.92K
Mar 9
Form 4
—
0
—
—
0
Feb 16
Form 4
+53.33%
5.71K
—
—
16.43K
Apr 22
Form 4
—
0
—
—
0
Feb 10
Form 4
+36.37%
2.86K
—
—
10.72K
Feb 10
Form 4
—
0
—
—
0
Jan 29
Form 4
+174.95%
5K
$4.98
$24,900.00
7.86K
Dec 19
Form 4
∞
2.86K
—
—
2.86K
Nov 20
Form 4
—
0
—
—
0
Mar 14
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Apr 21
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Nov 20
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Mar 4
No matching records found

AVANIR PHARMACEUTICALS, INC. No price found

Investor

Charles Mathews owns 53,183 units of Class A Common Stock and 270,094 units of Common Stock. From 2010 to 2012 Charles Mathews acquired a total of 150,683 shares in AVANIR PHARMACEUTICALS, INC..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5K
$2.69
$13,473.00
5K
Mar 6
Form 4
+12.50%
30K
—
—
270.09K
Feb 16
Form 4
+14.28%
30K
—
—
240.09K
Feb 8
Form 4/A
+23.52%
40K
—
—
210.09K
Feb 18
Form 4
+23.26%
40K
—
—
211.97K
Feb 18
Form 4
+53.59%
60K
—
—
171.97K
Feb 19
Form 4
+103.37%
56.91K
—
—
111.97K
Feb 21
Form 4
+495.22%
44.25K
—
—
53.18K
Mar 1
Form 4
+257.40%
6.43K
—
—
8.94K
Feb 13
Form 4
—
0
—
—
0
Mar 17
Form 4
—
0
—
—
0
Apr 6
No matching records found